日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tocilizumab Efficacy Across Inflammatory Subphenotypes in COVID-19-Related Acute Respiratory Distress Syndrome

托珠单抗对 COVID-19 相关急性呼吸窘迫综合征不同炎症亚表型的疗效

Filippini, Daan F L; Khyali, Jessica; Janssen, Malou; Rademaker, Emma; Cremer, Olaf L; van der Poll, Tom; van Amstel, Rombout B E; Endeman, Henrik; Bos, Lieuwe D J

Increasing inflammatory biomarkers are associated with mortality in critically ill COVID-19 patients despite anti-inflammatory treatment

尽管接受了抗炎治疗,但炎症生物标志物的升高仍与重症 COVID-19 患者的死亡率相关。

Daenen, Katrijn; Rizopoulos, Dimitris; Dalm, Virgil A S H; Huijben, Jilske A; Stoof, Sara C M; Nagtzaam, Nicole M A; Dik, Willem A; Swagemakers, Sigrid M A; van der Spek, Peter J; Tong-Minh, Kirby; Mersha, Daniel G Aynekulu; Khyali, Jessica; Juffermans, Nicole P; Gommers, Diederik; van Gorp, Eric C M; Bos, Lieuwe D J; Endeman, Henrik